Feasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily Injections

NCT01073566 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DEVICE: Finesse
DEVICE: Pen/Syringe (Usual injection device)

Sponsor

Calibra Medical, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]